Voltaren 50

Voltaren 50 is a medicine authorised by Swissmedic under authorisation number 39254. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 May 1975 and the authorisation is valid without a time limit. ATC code M01AB05 places the medicine in the group Anti-inflammatory and antirheumatic products.

  • Dispensing category B
  • Authorisation number 39254
  • ATC M01AB05
  • Synthetic medicines
Authorisation data
Authorisation number39254
NameVoltaren 50
Full nameVoltaren 50, Suppositorien
Authorisation holderNovartis Pharma Schweiz AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeM01AB05
First authorisation12 May 1975
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Voltaren 50, SuppositorienB12 May 1975
2Voltaren 100, SuppositorienB07 October 1977
3Voltaren 25, SuppositorienB23 June 1978
4Voltaren 12,5, SuppositorienB07 April 1983

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1810SuppositorienM01AB0507.10.1.B
2650SuppositorienM01AB0507.10.1.B
345SuppositorienM01AB0507.10.1.B
4250SuppositorienM01AB0507.10.1.B
5010SuppositorienM01AB0507.10.1.B
7710SuppositorienM01AB0507.10.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Voltaren 50 authorised in Switzerland?

Yes. Voltaren 50 is authorised by Swissmedic under authorisation number 39254, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Voltaren 50 have?

Voltaren 50 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Voltaren 50?

The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com